Glymtop GZ is a fixed-dose combination of Gliclazide 80 mg and Metformin 500 mg, used in the treatment of type 2 diabetes mellitus in adults. It is prescribed alongside proper diet and regular exercise to help achieve better glycemic control when monotherapy is insufficient. Gliclazide works by stimulating the pancreas to release insulin, helping lower blood glucose levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they provide balanced and effective control of blood sugar levels.
Gliclazide 80 mg increases insulin secretion to lower blood glucose, while Metformin 500 mg reduces hepatic glucose production and enhances insulin sensitivity, together improving glycemic control in type 2 diabetes.
Improves Blood Glucose Control: Helps maintain stable blood sugar levels throughout the day.
Dual-Mechanism Action: Combines insulin release stimulation with improved insulin sensitivity.
Supports Long-Term Diabetes Management: Reduces the risk of diabetes-related complications with regular use.
Effective When Monotherapy Is Insufficient: Ideal for patients needing combination antidiabetic therapy.
Clinically Trusted Formulation: Widely prescribed under medical supervision.
Take the tablet exactly as prescribed by a healthcare professional, along with meals. Regular monitoring of blood glucose levels is recommended.
May include low blood sugar, nausea, stomach upset, dizziness, or headache. Consult a healthcare provider if side effects persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Gliclazide 80 mg & Metformin 500 mg Tablets IP sourced from reputed pharmaceutical manufacturers. Glymtop GZ is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.